Related Experiment Video

Updated: Aug 2, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

[Nuclear factor kappa B activity and cell viability of SMMC-7721 inhibited by mutated inhibitor kappa B alpha]

Jian-hong Wang1, Qing-ke Huang, Min-xin Chen

  • 1Department of Gastroenterology, First Affiliated Hospital, Wenzhou Medical College, Wenzhou 325000, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|April 30, 2003
PubMed
Abstract

Insights

Transfecting mutated inhibitor kappa B alpha (mIκBα) into liver cancer cells inhibited NF-kappaB activity and suppressed cell growth. This targeted approach shows potential for liver cancer therapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Hepatology

Background:

  • Nuclear factor-kappa B (NF-κB) is a key transcription factor involved in cell proliferation, survival, and inflammation.
  • Dysregulation of NF-κB signaling is implicated in the development and progression of various cancers, including liver cancer.
  • Targeting NF-κB pathways presents a potential therapeutic strategy for hepatocellular carcinoma.

Purpose of the Study:

  • To investigate the inhibitory effects of mutated inhibitor kappa B alpha (mIκBα) on NF-κB activity and cell viability in the SMMC-7721 liver cancer cell line.
  • To assess the impact of mIκBα transfection on NF-κB nuclear translocation and expression.
  • To evaluate the effect of mIκBα on the proliferation of SMMC-7721 cells.

Main Methods:

  • SMMC-7721 cells were transfected with mIκBα plasmid or an empty pcDNA3 vector.
  • Electrophoretic mobility shift assay (EMSA) was used to determine NF-κB binding activity.
  • Western blot analysis was performed to assess NF-κB expression.
  • Cell viability assays were conducted to quantify cell proliferation.

Main Results:

  • Transfection with mIκBα significantly inhibited NF-κB nuclear translocation in SMMC-7721 cells at multiple time points (0, 24, 48, and 96 hours).
  • NF-κB expression was undetectable in nucleic protein extracts from mIκBα-transfected cells.
  • Cell growth was markedly suppressed in mIκBα-transfected cells compared to control and vector-transfected cells, with a notable effect observed on the second day.

Conclusions:

  • Stable expression of mIκBα effectively inhibits NF-κB nuclear translocation in SMMC-7721 liver cancer cells.
  • The inhibition of NF-κB signaling by mIκBα leads to the suppression of cancer cell growth.
  • mIκBα represents a promising therapeutic target for inhibiting liver cancer progression.

More Related Videos

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...